The incidence and severity of chronic intravascular hemolysis was evaluated in a total of 41 patients following mitral valve replacement. Valve replacement was with a gamma-radiated frame-mounted aortic homograft in 21 patients and with a composite seat Starr-Edwards prosthesis, model 6310 or 6320, in 20 patients. The parameters used to assess hemolysis were hemoglobin, hematocrit, reticulocyte count, red cell fragment count, serum haptoglobin, LDH and HBD, hemosiderin in the urine and red cell survival. 
clinically to be functioning well. All investigations were carried out 4 months to 3 yr after operation in the homograft series, and 6W2 months to 5 yr postoperatively in the prosthetic series. The age distribution in the homograft group was between 33 and 59 years with a mean of 46.7 years and in the Starr-Edwards group between 30 and 60 years with a mean of 45 years. The sex distribution was similar in both groups.
Hemoglobin estimation was made by the routine cyanmethemoglobin method. The hematocrit was measured by micro-hematocrit using ultra centrifugation. The red cell fragment count was enumerated on 1,000 red cells from peripheral blood films, made from blood collected in ethylenediamine tetracetate (EDTA), fixed with methyl alcohol and stained with Leishmanns Freshly voided urine was centrifuged and examined microscopically for red cells; if none were found a 'hemostix' was used to test for hemoglobinuria. A 20 ml sample of urine was centrifuged at 5,000 rev/min and some of the deposit spread on two glass slides. The smears were heat fixed and then alcohol fixed for 10 min. They were then stained for 25-30 min with a mixture of equal volumes of 20% v/v hydrochloric acid and 10% w/v freshly prepared potassium ferrocyanide. After this the slides were washed in water for 15-20 min to remove excess of acid and counter-stained with Neutral red (0.1%) for 30-60 sec. Iron containing pigment appeared as isolated or grouped, blue staining granules. These were examined using a microscope objective 43X under oil immersion and a scale of scoring adopted for hemosiderinuria which ranged from 0-4 plusses.
Red cell survival studies using radioactive 51Cr were carried out with autologous cells in 10 patients with homografts and 10 with Starr-Edwards prosthesis. All patients were tested on more than one occasion. The level of significance (P) of the difference between two means was obtained from the standard error of each mean, using the Student t-test. A similar method, using the standard error of each proportion was employed to obtain the level of significance of the difference between the proportions. incompetence around an aortic valve prosthesis or when, during systole, the lumen of a prosthetic valve is small relative to the stroke volume, or when a ball in a ball valve is large relative to the diameter of the aorta. Pirofsky et al. 15 suggested that mechanical destruction is not the whole explanation and that sometimes an autoimmune mechanism may be partly responsible for the hemolysis. They postulated that damage to the red cells might either unmask or modify surface antigens, with the resultant formation of autoantibodies against them.
Results

None
All the patients in this study have been carefully assessed clinically on several occasions to eliminate possible contributory causes of hemolysis. We found no clinical evidence of valve dysfunction in any of them, no electrocardiographic evidence of recent myocardial damage, nor did they have any detectable red cell antibodies by direct and indirect anti-human globulin tests.
We have based our hematologic evaluation of the incidence and severity of hemolysis on the following modification of a classification formulated by Eyster, Rothchild and Mychajliw.9 negative Mild: Hemosiderinuria, low or absent haptoglobins, but schistocytes < 10/1,000 red cells, reticulocytes < 3.5%, LDH < 400 I.U./L at 25°C.
Moderate: Hemosiderinuria, low or absent haptoglobins, but schistocytes > 10/1,000 red cells, reticulocytes > 3.5%, LDH > 400 I.U./L at 25°C.
Severe: All the above but hemoglobinuria also present.
In the present study, 85% of patients with a StarrEdwards mitral valve replacement showed evidence of chronic intravascular hemolysis, which was mild in 35% and moderate in 65%. None of the patients with a homograft showed any comparable evidence of hemolysis.
The hemoglobin level is the least significant index of hemolysis since some patients can maintain a p <0O001 
